| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |